Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glaxosmithkline consumer healthcare (uk) trading limited - fenilefrin; gvaifenezin; paracetamol - kapsula, trda - fenilefrin 5 mg / 1 kapsula  gvaifenezin100 mg / 1 kapsula  paracetamol500 mg / 1 kapsula; gvaifenezin 100 mg / 1 kapsula  paracetamol500 mg / 1 kapsula; paracetamol 500 mg / 1 kapsula - paracetamol, kombinacije brez psiholeptikov

Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glaxosmithkline consumer healthcare (uk) trading limited - fenilefrin; gvaifenezin; paracetamol - prašek za peroralno raztopino - fenilefrin 10 mg / 1 g  gvaifenezin200 mg / 1 g  paracetamol1000 mg / 1 g; gvaifenezin 200 mg / 1 g  paracetamol1000 mg / 1 g; paracetamol 1000 mg / 1 g - paracetamol, kombinacije brez psiholeptikov

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 150mg;   - film coated tablet - 150 mg - active: lamivudine 150mg   excipient: magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g sodium starch glycolate - 3tc in combination with other anti-retroviral agents is indicated for the treatment of hiv infected adults and children.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 300mg;   - film coated tablet - 300 mg - active: lamivudine 300mg   excipient: magnesium stearate microcrystalline cellulose opadry grey ys-1-17506a sodium starch glycolate

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 10 mg/ml;   - oral solution - 10 mg/ml - active: lamivudine 10 mg/ml   excipient: banana flavour 59.256 ap0551 citric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate strawberry flavour 057883 ap0551 sucrose - 3tc in combination with other anti-retroviral agents is indicated for the treatment of hiv infected adults and children.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - benzoyl peroxide 66.7 mg/g; clindamycin phosphate 12.8 mg/g;   - topical gel - 1%w/w, 5%w/w - active: benzoyl peroxide 66.7 mg/g clindamycin phosphate 12.8 mg/g   excipient: carbomer 940 colloidal silicon dioxide dimeticone disodium edetate dihydrate disodium lauryl sulfosuccinate glycerol poloxamer purified water sodium hydroxide - for the topical treatment of comedo, papular and pustular acne vulgaris.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - isotretinoin 0.05%{relative} (2% overage added);   - topical gel - 0.05% w/w - active: isotretinoin 0.05%{relative} (2% overage added)   excipient: butylated hydroxytoluene ethanol hyprolose - isotrex gel is indicated for the topical treatment of mild to moderate acne vulgaris, characterised by papules and pustules.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - valaciclovir hydrochloride 1112mg equivalent to valaciclovir 1000 mg;   - film coated tablet - 1000 mg - active: valaciclovir hydrochloride 1112mg equivalent to valaciclovir 1000 mg   excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water - · valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - valaciclovir hydrochloride 278mg equivalent to valaciclovir 250 mg;  ; valaciclovir hydrochloride 278mg equivalent to valaciclovir 250 mg - film coated tablet - 250 mg - active: valaciclovir hydrochloride 278mg equivalent to valaciclovir 250 mg   excipient: carnauba wax colloidal silicon dioxide crospovidone edible ink blue brilliant 5312 magnesium stearate microcrystalline cellulose opadry white oy-s-28861 povidone purified water   active: valaciclovir hydrochloride 278mg equivalent to valaciclovir 250 mg excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white oy-s-28861 povidone purified water   - valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 250mg (as the freeze -dried sodium salt) - powder for infusion - 250 mg - active: aciclovir 250mg (as the freeze -dried sodium salt) excipient: sodium hydroxide water for injection - zovirax iv for infusion is indicated for the treatment of herpes simplex infections. zovirax iv for infusion is indicated for the prophylaxis of herpes simplex infections in immune compromised patients. zovirax iv for infusion is indicated in the treatment of varicella zoster infections. zovirax iv for infusion is indicated for the treatment of herpes simplex infections in the neonate. zovirax iv for infusion is indicated for prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous zovirax reduces the incidence and delays the onset of cmv infection. when high dose intravenous zovirax is followed by 6 months treatment with high dose oral zovirax (see prescribing information for oral zovirax) mortality and the incidence of viraemia are also reduced.